Delivery Order SPE2DB22D2206-SPE2DB24FFX60
- Not listed
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $1,010.49 for naloxone hydrochloride on September 17, 2025, with an ultimate completion date of September 18, 2025. This competitively awarded, firm fixed-price contract was performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order contract worth $15,832.80 to AmerisourceBergen Drug Corp's Corporate Office division. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 between DLA and AmerisourceBergen, which serves as the primary vehicle for the company to supply a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide....
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Naloxone 0.4 mg/ml vials, with a contract ceiling value of $2,310.50. This firm fixed-price delivery order, awarded on August 7, 2025, with an ultimate completion date of August 8, 2025, represents a competitive award with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) Troop Support Medical with a potential value of $2,480.47. The contract is for the delivery of 25 units of 10 ml naloxone, a critical opioid overdose reversal medication, to support military treatment programs and facilities. This delivery order falls under a larger indefinite delivery contract (IDC) awarded solely to...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,557,196,796 units of Naloxone HCL 2ML 10S, a critical pharmaceutical product, with a potential value of $10,490.35. This delivery order contract is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of up to $999,999,999.00 and a...
- The Defense Logistics Agency Troop Support Medical awarded a $786.52 firm fixed price delivery order to Amerisourcebergen Drug Corp Corporate Office Division for 4562204243! Naloxone Hydrochloride. Amerisourcebergen Corporation, the parent company of Amerisourcebergen Drug Corp, will perform the work under the contract from its location in Conshohocken, Pennsylvania between September 8-11, 2023. No subcontractors or set aside designations were identified. The Defense Logistics Agency manages the...
- Amerisourcebergen Drug Corporation, operating as Amerisourcebergen, has been awarded a $7,184.69 firm fixed price delivery order by the Defense Logistics Agency Troop Support Medical (DLA) to provide 4561694843 Naloxone 4 mg/10 ml vials. Place of performance will be Amerisourcebergen's Conshohocken, Pennsylvania facility. The single day order running from August 3 to August 4, 2023 is associated with DLA's medical product procurement efforts which supply critical pharmaceuticals and medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Naloxone 0.4 mg/mL vials with a ceiling value of $1,444.42. This is a firm fixed-price delivery order with an ultimate completion date of August 4, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support Medical (SPE2DX), valued at $999.99 billion through December 2026. The contract contains no...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide Naloxone 0.4 mg/mL vials. The contract has a ceiling value of $5,132.76 and a performance period through April 12, 2024. This delivery order is issued under an existing indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp, which has a potential value of $999,999,999.00 and a...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Naloxone Hydrochloride, valued at $1,206.73. This firm fixed price delivery order, with an ultimate completion date of September 18, 2025, represents a non-competitive award under an existing contract vehicle. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB24FFX60Delivery Order
The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract worth $1,432.05 to provide NALOXONE 0.4 MG/ML vials. The contract has a completion date of March 6, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division located in Conshohocken, Pennsylvania, is providing these pharmaceutical products to support military treatment programs and facilities. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to deliver a comprehensive range of medications and healthcare materials to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designation was used for this contract award.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 3/5/24 |